Abbott Laboratories
XBER:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XBER:ABL
|
US |
|
SSE PLC
F:SCTA
|
UK |
|
C
|
Ceconomy AG
DUS:CEC
|
DE |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
Flame Acquisition Corp
NYSE:SOC
|
US |
|
Capital Ltd
OTC:CAPFF
|
UK |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 118.66 EUR with a low forecast of 99.43 EUR and a high forecast of 136.48 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
118.66
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 118.66 EUR with a low forecast of 99.43 EUR and a high forecast of 136.48 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
18%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
